BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 22641573)

  • 1. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P; Wu X; Shui H; Jia R
    J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin inhibits angiotensin II-induced nuclear factor kappa B activation in renal tubular epithelial cells through the p38 MAPK pathway.
    Gao P; Wu X; Shui H; Jia R
    Mol Biol Rep; 2012 Apr; 39(4):4719-25. PubMed ID: 21947850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38 mitogen-activated protein kinase and nuclear factor-κB facilitate CD40-mediated salivary epithelial cell death.
    Ping L; Ogawa N; Zhang Y; Sugai S; Masaki Y; Weiguo X
    J Rheumatol; 2012 Jun; 39(6):1256-64. PubMed ID: 22505709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvastatin prevents oxidized low-density lipoprotein-induced injury of renal tubular epithelial cells by inhibiting the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Chu G; Jia R; Yang D
    J Nephrol; 2006; 19(3):286-95. PubMed ID: 16874687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein.
    Wang HR; Li JJ; Huang CX; Jiang H
    Clin Chim Acta; 2005 Mar; 353(1-2):53-60. PubMed ID: 15698590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
    Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells.
    Ahad A; Ahsan H; Mujeeb M; Siddiqui WA
    Chem Biol Interact; 2015 Oct; 240():292-303. PubMed ID: 26341651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin inhibits activation of JAK and STAT proteins in diabetic rat glomeruli and mesangial cells under high glucose conditions.
    Shi YH; Zhao S; Wang C; Li Y; Duan HJ
    Acta Pharmacol Sin; 2007 Dec; 28(12):1938-46. PubMed ID: 18031608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line.
    Qi XF; Kim DH; Yoon YS; Li JH; Jin D; Teng YC; Kim SK; Lee KJ
    Br J Pharmacol; 2009 Aug; 157(8):1441-50. PubMed ID: 19594754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on anti-oxidant enzyme activities and renal function in streptozotocin-induced diabetic rats.
    Kurusu A; Shou I; Nakamura S; Fukui M; Shirato I; Tomino Y
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):767-70. PubMed ID: 11022967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells.
    Potena L; Frascaroli G; Grigioni F; Lazzarotto T; Magnani G; Tomasi L; Coccolo F; Gabrielli L; Magelli C; Landini MP; Branzi A
    Circulation; 2004 Feb; 109(4):532-6. PubMed ID: 14744969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadmium-induced apoptosis in rat kidney epithelial cells involves decrease in nuclear factor-kappa B activity.
    Xie J; Shaikh ZA
    Toxicol Sci; 2006 May; 91(1):299-308. PubMed ID: 16478757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
    Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
    Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
    J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy.
    Ahad A; Ganai AA; Mujeeb M; Siddiqui WA
    Chem Biol Interact; 2014 Aug; 219():64-75. PubMed ID: 24877639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.